Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.
- Genevieve Douglas
- , Claire Harrison
- , Cecily Forsyth
- , Michael Bennett
- , William Stevenson
- , John Hounsell
- , Sumita Ratnasingam
- , David Ritchie
- , David Ross
- , Andrew Grigg
Research output: Contribution to journal › Article › peer-review
14
Citations
(Scopus)